Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: iRhythm Technologies Secures $17 Million in Financing

Posted in Life Sciences Investing

iRhythm Technologies has announced it completed raising $17 million in series E financing.

iRhythm, headquartered in San Francisco, is a privately held healthcare information services company that focuses on the management of cardiac arrhythmia information.

The financing round was led by Novo A/S, a global life science investment firm.

Norwest Venture Partners, which led iRhythm’s series D financing, also participated in the oversubscribed round.

iRhythm indicated it will use the proceeds from the series E financing round to accelerate market growth for its ZIO Service, a long-term, continuous cardiac monitoring option expand technology; for development; and to continue to establish clinical evidence supporting ZIO Service.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.